Cardiac Assist Devices Market Global Segments, Top Key Players, Size and Recent Trends by Forecast to 2026

Logo

Albany, NY -- (SBWire) -- 10/23/2018 --Cardiac Assist Devices (CAD) are a type of mechanical pumps that work along with the heart to improve its pumping efficiency and maintain optimum blood flow throughout the body. Cardiac assist devices are used to treat end stage heart failure and are determined by the needs of the individual. These are designed to take over the function of the heart when it becomes weak and help it function normal. Cardiac assist devices are of three types: ventricular assist devices, intra-aortic balloon pumps (IABPs), and total artificial heart. Ventricular assist device is implanted in the patient's chest and consists of an electric motor and a driveline. It pumps blood through the heart to the entire body and has the required force to distribute sufficient blood throughout the body. Intra-aortic balloon pump is a long skinny balloon that controls the flow of blood through the aorta, which is the largest blood vessel. The device expands and contacts according to blood flow. It gets smaller when the heart pumps, so that blood can flow out to the rest of the body. It gets bigger when the heart relaxes in order to keep more blood in the heart.

View Report: https://www.transparencymarketresearch.com/cardiac-assist-devices.html

Rise in prevalence of cardiovascular diseases, increase in novel treatments, affordability of medical devices, high adoption and acceptance of cardiac assist devices in developing markets, and innovation and development in medical devices drive the cardiac assist devices market. Moreover, the global aging population and lack of donors for heart transplantation are boosting the implantation of cardiac assist devices in patients with severe heart complications. However, steep competition among existing players, complications and severity involved in the treatment, and lack of awareness among the rural population in developing and underdeveloped economies are likely to restrain the cardiac assist devices market.

The global cardiac assist devices market can be classified based on product type, modality, application, and region. In terms of product type, the global cardiac assist devices market can be segmented into ventricular assist devices, intra-aortic balloon pumps (IABPs), and total artificial heart. Further ventricular assist devices can be divided into left ventricular assist devices (LVADs), right ventricular assist devices (RVADs), and biventricular assist devices (BIVADs). The ventricular assist devices segment is likely to hold a major share of the cardiac assist devices market due to high acceptability of the product among patients. Moreover, the device does not restrict the movement of patients who have it implanted in their heart. By modality, the global cardiac assist devices market can be segmented into transcutaneous and implantable. Application of cardiac assist devices can be classified into bridge-to-transplant (BTT) therapy, destination therapy, bridge-to-recovery (BTR) therapy, and bridge-to-candidacy (BTC) therapy.

Request a Brochure of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1810

Based on region, the global cardiac assist devices market can be bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In 2017, North America dominated the global cardiac assist devices market due to high prevalence of cardiovascular diseases and presence of key players in the region. Asia Pacific and Latin America are emerging markets and are anticipated to expand at a considerable pace during the forecast period due to increase in incidence of heart failure, expansion of the health care industry, and increase in government investment to develop health care infrastructure in these regions. The cardiac assist devices market in countries such as China, India, and Brazil is projected to expand at a significant growth rate during the forecast period due to increase in awareness among people about heart diseases and their treatment.

Major players operating in the cardiac assist devices market include Abiomed, Berlin Heart, CardiacAssist, Inc., Cardiobridge GmbH, Carmat, HeartWare, Jarvik Heart, Inc., XENIOS AG, MiTiHeart Corporation, and SynCardia Systems, LLC.

Request TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=1810

About Transparency Market Research
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR's syndicated reports strive to provide clients to serve their overall research requirement.

Contact Us
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com

Media Relations Contact

Rohit Bhisey
AVP Marketing
1-518-618-1030
https://www.transparencymarketresearch.com/de-ionized-pineapple-concentrate-market.html

View this press release online at: http://rwire.com/1067279